Clinical trial
A Safety Study of Combination Treatment With Avonex and Placebo-Controlled…
NCT00217295 · Multiple Sclerosis Institute, Other · Unknown status
Key facts
| NCT number | NCT00217295 |
|---|---|
| Title | A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis |
| Official title | A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis. |
| Lead sponsor | Multiple Sclerosis Institute, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | Avonex and Topamax |
| Enrollment | 30 |
| Start date | Apr 1, 2004 |
| Completion | Dec 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Sep 22, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: